Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization
Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were...
Gespeichert in:
Veröffentlicht in: | International journal of biological macromolecules 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 124919 |
---|---|
container_issue | Pt 2 |
container_start_page | 124919 |
container_title | International journal of biological macromolecules |
container_volume | 242 |
creator | Dahiya, Mandeep Awasthi, Rajendra Yadav, Jaya Parkash Sharma, Shammi Dua, Kamal Dureja, Harish |
description | Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines).
•Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles. |
doi_str_mv | 10.1016/j.ijbiomac.2023.124919 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2815246565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813023018135</els_id><sourcerecordid>2815246565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</originalsourceid><addsrcrecordid>eNqFkMFu1DAQQC1URJfCL1Q-9pLFEydOwolq1QWkSlzgbI3tCXWU2IudrVS-vi7b9srFY828mdE8xi5BbEGA-jRt_WR8XNBua1HLLdTNAMMbtoG-GyohhDxjGwENVD1Icc7e5zyVrGqhf8fOZQeD6qDbsGl359eYMXCDmRzPMeFIwRtesg8zrsTniK5UFvwdaPWWBwzxgKl8Z8qf-T6m5VhAHwPH4LgP1b1fU-T2DhPalZL_-6_6gb0dcc708TlesF_7m5-7b9Xtj6_fd9e3lZWqX8trpES0RjW9RWeGprYKG0Iy1kkHoxuUGlsiFMK2tlUAXY1OKTPKWlglL9jVae4hxT9HyqtefLY0zxgoHrOue2jrRrWqLag6oTbFnBON-pD8gulBg9BPnvWkXzzrJ8_65Lk0Xj7vOJqF3Gvbi9gCfDkBVC6995R0tp6CJecT2VW76P-34xFaMJVz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2815246565</pqid></control><display><type>article</type><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><source>Elsevier ScienceDirect Journals</source><creator>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</creator><creatorcontrib>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</creatorcontrib><description>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines).
•Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2023.124919</identifier><identifier>PMID: 37196717</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Chitosan nanoparticle ; Cytotoxicity ; Ionic-gelation ; Magnetic nanoparticle ; MTT assay ; Sorafenib</subject><ispartof>International journal of biological macromolecules, 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</citedby><cites>FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0141813023018135$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37196717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dahiya, Mandeep</creatorcontrib><creatorcontrib>Awasthi, Rajendra</creatorcontrib><creatorcontrib>Yadav, Jaya Parkash</creatorcontrib><creatorcontrib>Sharma, Shammi</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><creatorcontrib>Dureja, Harish</creatorcontrib><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines).
•Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</description><subject>Chitosan nanoparticle</subject><subject>Cytotoxicity</subject><subject>Ionic-gelation</subject><subject>Magnetic nanoparticle</subject><subject>MTT assay</subject><subject>Sorafenib</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkMFu1DAQQC1URJfCL1Q-9pLFEydOwolq1QWkSlzgbI3tCXWU2IudrVS-vi7b9srFY828mdE8xi5BbEGA-jRt_WR8XNBua1HLLdTNAMMbtoG-GyohhDxjGwENVD1Icc7e5zyVrGqhf8fOZQeD6qDbsGl359eYMXCDmRzPMeFIwRtesg8zrsTniK5UFvwdaPWWBwzxgKl8Z8qf-T6m5VhAHwPH4LgP1b1fU-T2DhPalZL_-6_6gb0dcc708TlesF_7m5-7b9Xtj6_fd9e3lZWqX8trpES0RjW9RWeGprYKG0Iy1kkHoxuUGlsiFMK2tlUAXY1OKTPKWlglL9jVae4hxT9HyqtefLY0zxgoHrOue2jrRrWqLag6oTbFnBON-pD8gulBg9BPnvWkXzzrJ8_65Lk0Xj7vOJqF3Gvbi9gCfDkBVC6995R0tp6CJecT2VW76P-34xFaMJVz</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Dahiya, Mandeep</creator><creator>Awasthi, Rajendra</creator><creator>Yadav, Jaya Parkash</creator><creator>Sharma, Shammi</creator><creator>Dua, Kamal</creator><creator>Dureja, Harish</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230701</creationdate><title>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</title><author>Dahiya, Mandeep ; Awasthi, Rajendra ; Yadav, Jaya Parkash ; Sharma, Shammi ; Dua, Kamal ; Dureja, Harish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-c3b33aacb648cadb942c6a4eaebcd3d1fd966f5eea00c5c561172ad66bf320c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chitosan nanoparticle</topic><topic>Cytotoxicity</topic><topic>Ionic-gelation</topic><topic>Magnetic nanoparticle</topic><topic>MTT assay</topic><topic>Sorafenib</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dahiya, Mandeep</creatorcontrib><creatorcontrib>Awasthi, Rajendra</creatorcontrib><creatorcontrib>Yadav, Jaya Parkash</creatorcontrib><creatorcontrib>Sharma, Shammi</creatorcontrib><creatorcontrib>Dua, Kamal</creatorcontrib><creatorcontrib>Dureja, Harish</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dahiya, Mandeep</au><au>Awasthi, Rajendra</au><au>Yadav, Jaya Parkash</au><au>Sharma, Shammi</au><au>Dua, Kamal</au><au>Dureja, Harish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>242</volume><issue>Pt 2</issue><spage>124919</spage><epage>124919</epage><pages>124919-124919</pages><artnum>124919</artnum><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>Biocompatible magnetic nanoparticles are used for various biomedical applications. This study reported the development of nanoparticles with magnetic properties by embedding magnetite particles in the drug-loaded, crosslinked matrix of chitosan. Sorafenib tosylate-loaded magnetic nanoparticles were prepared by a modified ionic-gelation method. Particle size, zeta potential, polydispersity index, and entrapment efficiency of nanoparticles were in the range of 95.6 ± 3.4 nm to 440.9 ± 7.3 nm, 12.8 ± 0.8 mV to 27.3 ± 1.1 mV, 0.289 ± 0.011 to 0.571 ± 0.011, and 54.36 ± 1.26 % to 79.67 ± 1.40 %, respectively. The XRD spectrum of formulation CMP-5 confirmed the amorphous nature of the loaded drug in nanoparticles. TEM image confirmed the spherical shape of nanoparticles. Atomic force microscopic image of formulation CMP-5 indicated a mean surface roughness of 10.3597 nm. The magnetization saturation of formulation CMP-5 was 24.74 emu/g. Electron paramagnetic resonance spectroscopy revealed that formulation CMP-5's g-Lande's factor was 4.27, which was extremely near to the 4.30 (usual for Fe3+ ions). Residual paramagnetic Fe3+ ions may be responsible for paramagnetic origin. The data suggests superparamagnetic nature of particles. Formulations released 28.66 ± 1.22 % to 53.24 ± 1.95 % and 70.13 ± 1.72 % to 92.48 ± 1.32 % of the loaded drug after 24 h in pH 6.8 and pH 1.2, respectively. The IC50 value of formulation CMP-5 was 54.75 μg/mL in HepG2 (human hepatocellular carcinoma cell lines).
•Sorafenib tosylate-loaded magnetic nanoparticles are prepare and optimize successfully by a modified ionic gelation method.•Nanoparticles were spherical (95.6 nm to 401.1 nm) with high drug encapsulation efficiency (54.36% to 79.67%).•In HepG2 cell lines, the IC50 value of optimized formulation was recorded to be 54.75 μg/mL.•The magnetization saturation for optimized formulation was 24.74 emu/g.•The g factor for optimized formulation was 4.27 suggesting superparamagnetic nature of the particles.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37196717</pmid><doi>10.1016/j.ijbiomac.2023.124919</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0141-8130 |
ispartof | International journal of biological macromolecules, 2023-07, Vol.242 (Pt 2), p.124919-124919, Article 124919 |
issn | 0141-8130 1879-0003 |
language | eng |
recordid | cdi_proquest_miscellaneous_2815246565 |
source | Elsevier ScienceDirect Journals |
subjects | Chitosan nanoparticle Cytotoxicity Ionic-gelation Magnetic nanoparticle MTT assay Sorafenib |
title | Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T15%3A09%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chitosan%20based%20sorafenib%20tosylate%20loaded%20magnetic%20nanoparticles:%20Formulation%20and%20in-vitro%20characterization&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Dahiya,%20Mandeep&rft.date=2023-07-01&rft.volume=242&rft.issue=Pt%202&rft.spage=124919&rft.epage=124919&rft.pages=124919-124919&rft.artnum=124919&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2023.124919&rft_dat=%3Cproquest_cross%3E2815246565%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2815246565&rft_id=info:pmid/37196717&rft_els_id=S0141813023018135&rfr_iscdi=true |